Referentielijst

Anand S (2013)
Anand S. Gabapentin for pruritus in palliative care. Am J Hosp Palliat Care. 2013 Mar;30(2):192-6.

Andrade A (2020)
Andrade A, Kuah CY, Martin-Lopez JE, Chua S, Shpadaruk V, Sanclemente G, Franco JV. Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD013128.

Ataei S (2019)
Ataei S, Kord L, Larki A, Yasrebifar F, Mehrpooya M, Seyedtabib M, Hasanzarrini M. Comparison of Sertraline with Rifampin in the treatment of Cholestatic Pruritus: A Randomized Clinical Trial. Rev Recent Clin Trials. 2019;14(3):217-223.

Aymard JP (1980)
Aymard JP, Lederlin P, Witz F, Colomb JN, Herbeuval R, Weber B. Cimetidine for pruritus in Hodgkin's disease. Br Med J. 1980 Jan 19;280(6208):151-2.

Bachs L (1989)
Bachs L, Parés A, Elena M, Piera C, Rodés J. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet. 1989 Mar 18;1(8638):574-6.

Bae BG (2012)
Bae BG, Oh SH, Park CO, Noh S, Noh JY, Kim KR, Lee KH. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Acta Derm Venereol. 2012 Jan;92(1):57-61.

Balak DMW (2021)
Balak DMW, Kemperman PMJH, Thio HB. Chronische jeuk. Ned Tijdschr Geneeskd 2021;165:D5199.

Baldo A (2002)
Baldo A, Sammarco E, Plaitano R, Martinelli V, Monfrecola. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol. 2002;147(5):979-81.

Ballinger AB (1994)
Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994 Apr;35(4):467-70.

Barkay O (2013)
Barkay O, Mosler P, Schmitt CM, Lehman GA, Frakes JT, Johanson JF, Qaseem T, Howell DA, Sherman S. Effect of endoscopic stenting of malignant bile duct obstruction on quality of life. J Clin Gastroenterol. 2013 Jul;47(6):526-31.

BC Centre for Palliative Care (2017)
BC Centre for Palliative Care. Inter-professional palliative care symptom guidelines. Pruritus, 2017. Beschikbaar op: https://bc-cpc.ca/wp-content/uploads/2019/03/Grey-BCPC-Clinical-Best-Practices-4-Pruritus.pdf.

Bergasa NV (1992)
Bergasa, N.V., et al., A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102(2):544-9.

Bergasa NV (1995)
Bergasa, N.V., et al., Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Annals of Internal Medicine. 1995;123(3):161-7.

Bergasa NV (1999)
Bergasa, N.V., et al., Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. Journal of the American Academy of Dermatology. 1999;41(3 Pt 1):431-4.

Bergasa NV (2006)
Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2006 Nov;44(5):1317-23.

Borgeat A (1993)
Borgeat A, Wilder-Smith OH, Mentha G. Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology. 1993 Jan;104(1):244-7.

Breuer-McHam J (1999)
Breuer-McHam J, Marshall G, Adu-Oppong A, Goller M, Mays S, Berger T, Lewis DE, Duvic M. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol. 1999 Jan;40(1):48-60.

Browning J (2003)
Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2003 Dec;98(12):2736-41.

Carey EJ (2015)
Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015 Oct 17;386(10003):1565-75.

Carlsson CP (2010)
Carlsson CP, Wallengren J. Therapeutic and experimental therapeutic studies on acupuncture and itch: review of the literature. J Eur Acad Dermatol Venereol. 2010;24(9):1013-6.

Cerio R (1987)
Cerio R, Murphy GM, Sladen GE, MacDonald DM. A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol. 1987 Feb;116(2):265-7.

Charuluxananan S (2000)
Charuluxananan S, Somboonviboon W, Kyokong O, Nimcharoendee K. Ondansetron for treatment of intrathecal morphine-induced pruritus after cesarean delivery. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):535-9.

Chida Y (2007)
Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol. 2007;144(1):1-9.

Chiravanich W (2012)
Chiravanich W, Oofuvong M, Kovitwanawong N. Single dose of gabapentin for prophylaxis intrathecal morphine-induced pruritus in orthopedic surgery: a randomized controlled trial. J Med Assoc Thai. 2012 Feb;95(2):186-90.

Cynamon HA (1990)
Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990 Apr;98(4):1013-6.

Decock S (2012)
Decock S, Roelandts R, Steenbergen WV, Laleman W, Cassiman D, Verslype C, et al. Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. J Hepatol. 2012;57(3):637-41.

Demierre MF (2006)
Demierre MF, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006 Sep;55(3):543-4.

Di Padova (1984)
Di Padova, C., et al., Double-blind placebo-controlled clinical trial of microporous colestyuramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids. Methods & Findings in Experimental & Clinical Pharmacology. 1984;6(12):773-6.

Duncan JS (1984)
Duncan JS, Kennedy HJ, Triger DR. Treatment of pruritus due to chronic obstructive liver disease. Br Med J (Clin Res Ed). 1984 Jul 7;289(6436):22.

Eschler DC (2010)
Eschler DC, Klein PA. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol. 2010 Aug;9(8):992-7.

European Association for the Study of the Liver (2009)
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009 Aug;51(2):237-67.

Fawaz B (2021)
Fawaz B, Chamseddin BH, Griffin JR. Defining the role of mirtazapine in the treatment of refractory pruritus. J Dermatolog Treat. 2021 Mar;32(2):132-6.

Fjellner B (1979)
Fjellner B, Hägermark O. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol. 1979;59(6):505-12.

Floreani (1988)
Floreani, A., et al. Diethylaminoethyldextran (DEAE-Dextran) for itching in primary biliary cirrhosis: a double blind trial. Medical science research, 1988. 16, 731?732.

Fowler E (2019)
Fowler E, Yosipovitch G. Chronic itch management: therapies beyond those targeting the immune system. Ann Allergy Asthma Immunol. 2019 Aug;123(2):158-165.

Ghent CN (1988)
Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988 Feb;94(2):488-93.

Gorin I (1989)
Gorin I, Lessana-Leibowitch M, Fortier P, Leibowitch J, Escande JP. Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. J Am Acad Dermatol. 1989 Mar;20(3):511-3.

Hanid MA (1980)
Hanid MA, Levi AJ. Phototherapy for pruritus in primary biliary cirrhosis. Lancet. 1980 Sep 6;2(8193):530.

Hercogová J (2005)
Hercogová J. Topical anti-itch therapy. Dermatologic Therapy 2005; 18(4):341-3.

Hohl CM (2015)
Hohl CM, Wong JK, Harlos MS. Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease. J Palliat Care. 2015;31(2):124-6.

Hwang J (2021)
Hwang J, Lio PA. Acupuncture in Dermatology: An Update to a Systematic Review. J Altern Complement Med. 2021 Jan;27(1):12-23.

Ibrahim IM (2017)
Ibrahim IM, Elsaie ML, Almohsen AM, Mohey-Eddin MH. Effectiveness of topical clove oil on symptomatic treatment of chronic pruritus. J Cosmet Dermatol. 2017 Dec;16(4):508-11.

IKNL (2011)
IKNL. Handreiking ‘Palliatieve zorg aan mensen met een niet-westerse achtergrond’. 2011. Beschikbaar op: https://www.pallialine.nl/index.php?pagina=/richtlijn/item/pagina.php&id=34562&richtlijn_id=824 [Bezocht op 3 mei 2021].

IKNL (2010)
IKNL. Richtlijn ‘Complementaire zorg’. 2010. Beschikbaar op https://www.pallialine.nl/complementaire-zorg [Bezocht op 21 juni 2021].

IKNL (2017)
IKNL. Richtlijn ‘Palliatieve zorg bij eindstadium nierfalen’. 2017. Beschikbaar op: https://www.pallialine.nl/nierfalen [Bezocht op 3 mei 2021].

IKNL/Palliactief (2017)
IKNL/Palliactief. Kwaliteitskader palliatieve zorg Nederland. 2017. Beschikbaar op: https://palliaweb.nl/publicaties/kwaliteitskader-palliatieve-zorg-nederland-public [Bezocht op 3 mei 2021].

Jackson N (1987)
Jackson N, Burt D, Crocker J, Boughton B. Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus. Br J Dermatol. 1987 Jan;116(1):21-9.

Jones EA (2002)
Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM. 2002 Aug;95(8):547-52.

Jones EA (2005)
Jones EA, Zylicz Z. Treatment of pruritus caused by cholestasis with opioid antagonists. J Palliat Med. 2005 Dec;8(6):1290-4.

Jones EA (2007)
Jones EA, Molenaar HA, Oosting J. Ondansetron and pruritus in chronic liver disease: a controlled study. Hepatogastroenterology. 2007 Jun;54(76):1196-9.

Juby (1994)
Juby, L.D., V.S. Wong, and M.S. Losowsky, Buprenorphine and hepatic pruritus. British Journal of Clinical Practice. 1994;48(6):331.

Kaptanoglu AF (2003)
Kaptanoglu AF, Oskay T. Ultraviolet B treatment for pruritus in Hodgkin’s lymphoma. J Eur Acad Dermatol Venereol. 2003;17(4):489-90.

Kaushik SB (2014)
Kaushik SB, Cerci FB, Miracle J, Pokharel A, Chen SC, Chan YH, Wilkin A, Yosipovitch G. Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol. 2014 Apr;70(4):659-664.

Khurana (2006)
Khurana, S. and P. Singh, Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver International. 2006;26(8):943-8.

Kjellberg F (2001)
Kjellberg F, Tramèr MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol. 2001 Jun;18(6):346-57.

Korfitis C (2008)
Korfitis C, Trafalis DT. Carbamazepine can be effective in alleviating tormenting pruritus in patients with hematologic malignancy. J Pain Symptom Manage. 2008 Jun;35(6):571-2.

Kouwenhoven TA (2017)
Kouwenhoven TA, van de Kerkhof PCM, Kamsteeg M. Use of oral antidepressants in patients with chronic pruritus: A systematic review. J Am Acad Dermatol. 2017 Dec;77(6):1068-1073.e7.

Kremer AE (2015)
Kremer AE, Namer B, Bolier R, Fischer MJ, Oude Elferink RP, Beuers U. Pathogenesis and Management of Pruritus in PBC and PSC. Dig Dis. 2015;33 Suppl 2:164-75.

Kuiper EM (2010)
Kuiper EM, van Erpecum KJ, Beuers U, Hansen BE, Thio HB, de Man RA, Janssen HL, van Buuren HR. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology. 2010 Oct;52(4):1334-40.

Kumada (2017)
Kumada, H., et al., Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: A randomized, double-blind trial. Hepatology Research. 2017;47(10):972-82.

Kung AT (2014)
Kung AT, Yang X, Li Y, Vasudevan A, Pratt S, Hess P. Prevention versus treatment of intrathecal morphine-induced pruritus with ondansetron. Int J Obstet Anesth. 2014 Aug;23(3):222-6.

Leslie TA (2015)
Leslie TA, Greaves MW, Yosipovitch G. Current topical and systemic therapies for itch. Handb Exp Pharmacol. 2015;226:337-56.

Lim HW (1997)
Lim HW, Vallurupalli S, Meola T, Soter NA. UVB phototherapy is an effective treatment for pruritus in patients infected with HIV. J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):414-7.

Mallo S (2008)
Mallo S, Coto P, Caminal L, Rayón C, Balbín M, Sánchez-Del Río J, Santos-Juanes J. Generalized pruritus as presentation of T-cell large granular lymphocyte leukaemia. Clin Exp Dermatol. 2008 May;33(3):348-9.

Marinangeli F (2009)
Marinangeli F, Guetti C, Angeletti C, Bonetti C, Paladini A, Piroli A, Varrassi G. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus. J Pain Symptom Manage. 2009 Oct;38(4):e5-8.

Matsuda KM (2016)
Matsuda KM, Sharma D, Schonfeld AR, Kwatra SG. Gabapentin and pregabalin for the treatment of chronic pruritus. J Am Acad Dermatol. 2016 Sep;75(3):619-625.e6.

Mayo MJ (2007)
Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007 Mar;45(3):666-74.

McCormick (1994)
McCormick, P.A., et al., Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. Journal of Hepatology. 1994;21(4):496-9.

Millington GWM (2018)
Millington GWM, Collins A, Lovell CR, Leslie TA, Yong ASW, Morgan JD, Ajithkumar T, Andrews MJ, Rushbook SM, Coelho RR, Catten SJ, Lee KYC, Skellett AM, Affleck AG, Exton LS, Mohd Mustapa MF, Levell NJ. British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018. Br J Dermatol. 2018 Jan;178(1):34-60.

Müller C (1998)
Müller C, Pongratz S, Pidlich J, Penner E, Kaider A, Schemper M, Raderer M, Scheithauer W, Ferenci P. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol. 1998 Oct;10(10):865-70.

NVVH (2019)
NVVH. Richtlijn ‘Pancreascarcinoom’. 2019. Beschikbaar op: https://richtlijnendatabase.nl/richtlijn/pancreascarcinoom/startpagina.html [Bezocht op 20 mei 2021].

O'Donoghue M (2005)
O'Donoghue M, Tharp MD. Antihistamines and their role as antipruritics. Dermatol Ther. 2005 Jul-Aug;18(4):333-40.

O'Donohue JW (2005)
O'Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther. 2005 Apr 15;21(8):1041-5.

Paech M (2015)
Paech M, Sng B, Ng L, Nathan E, Sia A, Carvalho B. Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial. Br J Anaesth. 2015 Mar;114(3):469-76.

Pan M (2013)
Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatol Online J. 2013;19(11):20392.

Patel T (2010)
Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother. 2010;11:1673–1682.

Person JR (1981)
Person JR. Ultraviolet A (UV-A) and cholestatic pruritus. Arch Dermatol. 1981 Nov;117(11):684.

Phan NQ (2012)
Phan NQ, Blome C, Fritz F et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92:502–7.

Pharos (2017)
Pharos. Lessen uit gesprekken over leven en dood. 2017. Beschikbaar op: https://www.pharos.nl/kennisbank/lessen-uit-gesprekken-over-leven-en-dood/ [Bezocht op 3 mei 2021].

Podesta A (1991)
Podesta A, Lopez P, Terg R, Villamil F, Flores D, Mastai R, Udaondo CB, Companc JP. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci. 1991 Feb;36(2):216-20.

Pojawa-Golab M (2019)
Pojawa-Golab M, Jaworecka K, Reich A. NK-1 Receptor Antagonists and Pruritus: Review of Current Literature. Dermatol Ther (Heidelb). 2019 Sep;9(3):391-405.

Polat M (2008)
Polat M, Oztas P, Ilhan MN, Yalçin B, Alli N. Generalized pruritus: a prospective study concerning etiology. Am J Clin Dermatol. 2008;9(1):39-44.

Pongcharoen (2016)
Pongcharoen, P. and A.B. Fleischer, An evidence-based review of systemic treatments for itch. European Journal of Pain (United Kingdom). 2016;20(1):24-31.

Prin M (2016)
Prin M, Guglielminotti J, Moitra V, Li G. Prophylactic Ondansetron for the Prevention of Intrathecal Fentanyl- or Sufentanil-Mediated Pruritus: A Meta-Analysis of Randomized Trials. Anesth Analg. 2016 Feb;122(2):402-9.

Reddy L (2007)
Reddy L, Krajnik M, Zylicz Z. Transdermal buprenorphine may be effective in the treatment of pruritus in primary biliary cirrhosis. J Pain Symptom Manage. 2007 Nov;34(5):455-6.

Rowe B (2016)
Rowe B, Yosipovitch G, Paraneoplastic Itch Management. Current problems in Dermatology 2016: 50:149-54.

Sarina B. Elmariah (2011)
Sarina B. Elmariah, Ethan A. Lerner. Semin Cutan Med Surg. Semin Cutan Med Surg. 2011 Jun; 30(2): 118–126.

Schworer (1995)
Schworer, H., H. Hartmann, and G. Ramadori, Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain. 1995;61(1):33-7.

Scottish Palliative Care Guidelines (2019)
Scottish Palliative Care Guidelines. Pruritus. 2019. Beschikbaar op: https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/pruritis.aspx [Bezocht op 30 mei 2021].

Scottish Palliative Care Guidelines (2020)
Scottish Palliative Care Guidelines. Pruritus. 2020. Beschikbaar op: https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/pruritis.aspx [Bezocht op 30 mei 2021].

Seckin D (2007)
Seckin D, Demircay Z, Akin O. Generalized pruritus treated with narrowband UVB. Int J Dermatol. 2007;46(4):367-70.

Sharma D (2016)
Sharma D, Kwatra SG. Thalidomide for the treatment of chronic refractory pruritus. J Am Acad Dermatol. 2016 Feb;74(2):363-9.

Sheen MJ (2008a)
Sheen MJ, Ho ST, Lee CH, Tsung YC, Chang FL. Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. Anesth Analg. 2008 Jun;106(6):1868-72.

Sheen MJ (2008b)
Sheen MJ, Ho ST, Lee CH, Tsung YC, Chang FL, Huang ST. Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus. Br J Anaesth. 2008 Nov;101(5):711-5.

Siemens (2016)
Siemens, W., et al., Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews. 2016;11:CD008320.

Smith KJ (1997)
Smith KJ, Skelton HG, Yeager J, Lee RB, Wagner KF. Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. Dermatology. 1997;195(4):353-8.

Ständer S (2007)
Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: aposition paper of the International Forum for the Study of Itch. Acta Derm Venereol. 2007;87(4):291-4

Ständer S (2009)
Ständer, S., et al., Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: Results of an open-labelled, two-arm proof-of-concept study. Acta Dermato-Venereologica. 2009;89(1):45-51.

Ständer S (2013)
Ständer S, Augustin M, Reich A et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol 2013; 93:509–14

Swanbeck G (1970)
Swanbeck G, Rajka G. Antipruritic effect of urea solutions. An experimental and clinical study. Acta Derm Venereol. 1970;50(3):225-7.

Szepietowski JC (2018)
Szepietowski JC, Reich A. BMJ Best Practice: Assessment of pruritus. 2018. Beschikbaar op: https://bestpractice.bmj.com/topics/en-gb/612. [Bezocht op 30 mei 2021].

Tandon P (2007)
Tandon P, Rowe BH, Vandermeer B, Bain VG. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol. 2007 Jul;102(7):1528-36.

Tefferi A (2002)
Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002 Apr 1;99(7):2627.

Terg R (2002)
Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol. 2002 Dec;37(6):717-22.

Teunissen SC (2007)
Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007 Jul;34(1):94-104.

To (2012)
To, T.H.M., et al., The role of ondansetron in the management of cholestatic or uremic pruritus - A systematic review. Journal of Pain and Symptom Management. 2012;44(5):725-30.

Turner IB (1994)
Turner IB, Rawlins MD, Wood P, James OF. Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis. Aliment Pharmacol Ther. 1994 Jun;8(3):337-42.

Twycross R (2003)
Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z. Itch: scratching more than the surface. QJM. 2003 Jan;96(1):7-26.

Villamil AG (2005)
Villamil AG, Bandi JC, Galdame OA, Gerona S, Gadano AC. Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Am J Med. 2005 Oct;118(10):1160-3.

Vincenzi B (2010)
Vincenzi B, Fratto ME, Santini D, Tonini G. Aprepitant against pruritus in patients with solid tumours. Support Care Cancer. 2010 Sep;18(9):1229-30.

Wang F (2020)
Wang F, Kim BS. Itch: A Paradigm of Neuroimmune Crosstalk. Immunity. 2020 May 19;52(5):753-66.

Wang W (2017)
Wang W, Zhou L, Sun L. Ondansetron for neuraxial morphine-induced pruritus: A meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2017 Aug;42(4):383-393.

Weisshaar E (2015)
Weisshaar E, Weiss M, Mettang T, Yosipovitch G, Zylicz Z; Special Interest Group of the International Forum on the Study of Itch. Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venereol. 2015 Mar;95(3):261-5.

Weisshaar E (2019)
Weisshaar E, Szepietowski J C, Dalgard F J, et al. European Guideline on chronic pruritus. Acta Derm Venereol. 2019;99:469-506.

Wolfhagen FH (1997)
Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997 Oct;113(4):1264-9.

Woolf GM (1990)
Woolf GM, Reynolds TB. Failure of rifampin to relieve pruritus in chronic liver disease. J Clin Gastroenterol. 1990 Apr;12(2):174-7.

Yosipovitch G (2013)
Yosipovitch G, Bernhard J D. Chronic pruritus. N Engl J Med. 2013;368:1625-34.

Yosipovitch G (2018)
Yosipovitch G, Ständer S, Kerby MB, Larrick JW, Perlman AJ, Schnipper EF, Zhang X, Tang JY, Luger T, Steinhoff M. Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial. J Am Acad Dermatol. 2018 May;78(5):882-891.e10.

Zand F (2015)
Zand F, Amini A, Asadi S, Farbood A. The effect of methylnaltrexone on the side effects of intrathecal morphine after orthopedic surgery under spinal anesthesia. Pain Pract. 2015 Apr;15(4):348-54.

Zylicz Z (2003)
Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003 Dec;26(6):1105-12.

Zylicz Z (2005)
Zylicz Z, Stork N, Krajnik M. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report. J Pain Symptom Manage. 2005 Jan;29(1):100-3.